NVCR Research and Charts

NVCR - NovoCure Ltd (Healthcare: Medical Instruments & Supplies)

Earnings Date: 2025-07-24 (Delayed quote data 2025-07-09)

Last 18.19	Change ⇑ +1.30 (+7.70%)	Volume 1,020,761
	Open 17.52	High 18.22	Low 17.52

8EMA (Daily) 17.63	40EMA (Daily) 17.67	50EMA (Daily) 17.80	STO (Daily) 60.558	MACD Hist (Daily) 0.145
8EMA (Weekly) 17.835	40EMA (Weekly) 19.49	50EMA (Weekly) 20.06	STO (Weekly) 51.369	MACD Hist (Weekly) 0.164


Company Profile
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.